These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23323893)

  • 1. New era of biologic therapeutics in atopic dermatitis.
    Guttman-Yassky E; Dhingra N; Leung DY
    Expert Opin Biol Ther; 2013 Apr; 13(4):549-61. PubMed ID: 23323893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, present, and future for biologic intervention in atopic dermatitis.
    Howell MD; Parker ML; Mustelin T; Ranade K
    Allergy; 2015 Aug; 70(8):887-96. PubMed ID: 25879391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging biologic and small molecule therapies for atopic dermatitis.
    Li R; Hadi S; Guttman-Yassky E
    Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
    Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
    Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis.
    Na CH; Baghoomian W; Simpson EL
    Acta Derm Venereol; 2020 Jun; 100(12):adv00165. PubMed ID: 32419031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and Emerging Biologics for Atopic Dermatitis.
    Baghoomian W; Na C; Simpson EL
    Am J Clin Dermatol; 2020 Aug; 21(4):457-465. PubMed ID: 32323259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
    Dubin C; Del Duca E; Guttman-Yassky E
    Expert Rev Clin Immunol; 2021 Aug; 17(8):835-852. PubMed ID: 34106037
    [No Abstract]   [Full Text] [Related]  

  • 9. Atopic dermatitis treatment: Current state of the art and emerging therapies.
    Silverberg JI
    Allergy Asthma Proc; 2017 Jul; 38(4):243-249. PubMed ID: 28668106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics for Atopic Dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atopic dermatitis: treatment and innovations in immunotherapy.
    Ferrara F; Zovi A; Capuozzo M; Langella R
    Inflammopharmacology; 2024 Jun; 32(3):1777-1789. PubMed ID: 38581639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.
    Schäbitz A; Eyerich K; Garzorz-Stark N
    J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
    David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
    Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atopic Dermatitis - Current State of Research on Biological Treatment.
    Klasa B; Cichocka-Jarosz E
    J Mother Child; 2020 Jul; 24(1):53-66. PubMed ID: 33074181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Atopic Dermatitis and Psoriasis Vulgaris: Implications for Targeted Biologic Therapy.
    Johnson MC; Bowers NL; Strowd LC
    Cutis; 2022 Feb; 109(2):110-112. PubMed ID: 35659797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
    Chun PIF; Lehman H
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
    Werfel T; Allam JP; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon HU; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
    J Allergy Clin Immunol; 2016 Aug; 138(2):336-49. PubMed ID: 27497276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of biologics in atopic dermatitis.
    Wu J; Guttman-Yassky E
    Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.